Emerging Treatments for Childhood Interstitial Lung Disease
This article summarizes current treatments and explores potential therapeutic options for patients suffering from chILD.PMID:37948041 | DOI:10.1007/s40272-023-00603-9 (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 10, 2023 Category: Pediatrics Authors: Nicol Bernardinello Matthias Griese Rapha ël Borie Paolo Spagnolo Source Type: research
Emerging Treatments for Childhood Interstitial Lung Disease
This article summarizes current treatments and explores potential therapeutic options for patients suffering from chILD.PMID:37948041 | DOI:10.1007/s40272-023-00603-9 (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 10, 2023 Category: Pediatrics Authors: Nicol Bernardinello Matthias Griese Rapha ël Borie Paolo Spagnolo Source Type: research
Emerging Treatments for Childhood Interstitial Lung Disease
This article summarizes current treatments and explores potential therapeutic options for patients suffering from chILD.PMID:37948041 | DOI:10.1007/s40272-023-00603-9 (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 10, 2023 Category: Pediatrics Authors: Nicol Bernardinello Matthias Griese Rapha ël Borie Paolo Spagnolo Source Type: research
Emerging Treatments for Childhood Interstitial Lung Disease
This article summarizes current treatments and explores potential therapeutic options for patients suffering from chILD.PMID:37948041 | DOI:10.1007/s40272-023-00603-9 (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 10, 2023 Category: Pediatrics Authors: Nicol Bernardinello Matthias Griese Rapha ël Borie Paolo Spagnolo Source Type: research
Emerging Treatments for Childhood Interstitial Lung Disease
This article summarizes current treatments and explores potential therapeutic options for patients suffering from chILD.PMID:37948041 | DOI:10.1007/s40272-023-00603-9 (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 10, 2023 Category: Pediatrics Authors: Nicol Bernardinello Matthias Griese Rapha ël Borie Paolo Spagnolo Source Type: research
Emerging Treatments for Childhood Interstitial Lung Disease
This article summarizes current treatments and explores potential therapeutic options for patients suffering from chILD.PMID:37948041 | DOI:10.1007/s40272-023-00603-9 (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 10, 2023 Category: Pediatrics Authors: Nicol Bernardinello Matthias Griese Rapha ël Borie Paolo Spagnolo Source Type: research
Emerging Treatments for Childhood Interstitial Lung Disease
This article summarizes current treatments and explores potential therapeutic options for patients suffering from chILD.PMID:37948041 | DOI:10.1007/s40272-023-00603-9 (Source: Paediatric Drugs)
Source: Paediatric Drugs - November 10, 2023 Category: Pediatrics Authors: Nicol Bernardinello Matthias Griese Rapha ël Borie Paolo Spagnolo Source Type: research
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs
Paediatr Drugs. 2023 Oct 30. doi: 10.1007/s40272-023-00601-x. Online ahead of print.ABSTRACTEpilepsy is a common pediatric neurological condition, affecting approximately 470,000 children in the USA and having a prevalence of 0.9% in the global population of approximately 2.6 billion children. Epilepsy is associated with disruptions in several areas of a child's life, including medical burden, quality of life, cognitive outcomes, and higher risk of mortality. Additionally, some pediatric patients may experience acute seizure emergencies such as seizure clusters (also called acute repetitive seizures), which are intermitten...
Source: Paediatric Drugs - October 30, 2023 Category: Pediatrics Authors: James W Wheless Barry Gidal Adrian L Rabinowicz Enrique Carrazana Source Type: research
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs
Paediatr Drugs. 2023 Oct 30. doi: 10.1007/s40272-023-00601-x. Online ahead of print.ABSTRACTEpilepsy is a common pediatric neurological condition, affecting approximately 470,000 children in the USA and having a prevalence of 0.9% in the global population of approximately 2.6 billion children. Epilepsy is associated with disruptions in several areas of a child's life, including medical burden, quality of life, cognitive outcomes, and higher risk of mortality. Additionally, some pediatric patients may experience acute seizure emergencies such as seizure clusters (also called acute repetitive seizures), which are intermitten...
Source: Paediatric Drugs - October 30, 2023 Category: Pediatrics Authors: James W Wheless Barry Gidal Adrian L Rabinowicz Enrique Carrazana Source Type: research
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs
Paediatr Drugs. 2023 Oct 30. doi: 10.1007/s40272-023-00601-x. Online ahead of print.ABSTRACTEpilepsy is a common pediatric neurological condition, affecting approximately 470,000 children in the USA and having a prevalence of 0.9% in the global population of approximately 2.6 billion children. Epilepsy is associated with disruptions in several areas of a child's life, including medical burden, quality of life, cognitive outcomes, and higher risk of mortality. Additionally, some pediatric patients may experience acute seizure emergencies such as seizure clusters (also called acute repetitive seizures), which are intermitten...
Source: Paediatric Drugs - October 30, 2023 Category: Pediatrics Authors: James W Wheless Barry Gidal Adrian L Rabinowicz Enrique Carrazana Source Type: research
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs
Paediatr Drugs. 2023 Oct 30. doi: 10.1007/s40272-023-00601-x. Online ahead of print.ABSTRACTEpilepsy is a common pediatric neurological condition, affecting approximately 470,000 children in the USA and having a prevalence of 0.9% in the global population of approximately 2.6 billion children. Epilepsy is associated with disruptions in several areas of a child's life, including medical burden, quality of life, cognitive outcomes, and higher risk of mortality. Additionally, some pediatric patients may experience acute seizure emergencies such as seizure clusters (also called acute repetitive seizures), which are intermitten...
Source: Paediatric Drugs - October 30, 2023 Category: Pediatrics Authors: James W Wheless Barry Gidal Adrian L Rabinowicz Enrique Carrazana Source Type: research
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs
Paediatr Drugs. 2023 Oct 30. doi: 10.1007/s40272-023-00601-x. Online ahead of print.ABSTRACTEpilepsy is a common pediatric neurological condition, affecting approximately 470,000 children in the USA and having a prevalence of 0.9% in the global population of approximately 2.6 billion children. Epilepsy is associated with disruptions in several areas of a child's life, including medical burden, quality of life, cognitive outcomes, and higher risk of mortality. Additionally, some pediatric patients may experience acute seizure emergencies such as seizure clusters (also called acute repetitive seizures), which are intermitten...
Source: Paediatric Drugs - October 30, 2023 Category: Pediatrics Authors: James W Wheless Barry Gidal Adrian L Rabinowicz Enrique Carrazana Source Type: research
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs
Paediatr Drugs. 2023 Oct 30. doi: 10.1007/s40272-023-00601-x. Online ahead of print.ABSTRACTEpilepsy is a common pediatric neurological condition, affecting approximately 470,000 children in the USA and having a prevalence of 0.9% in the global population of approximately 2.6 billion children. Epilepsy is associated with disruptions in several areas of a child's life, including medical burden, quality of life, cognitive outcomes, and higher risk of mortality. Additionally, some pediatric patients may experience acute seizure emergencies such as seizure clusters (also called acute repetitive seizures), which are intermitten...
Source: Paediatric Drugs - October 30, 2023 Category: Pediatrics Authors: James W Wheless Barry Gidal Adrian L Rabinowicz Enrique Carrazana Source Type: research
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs
Paediatr Drugs. 2023 Oct 30. doi: 10.1007/s40272-023-00601-x. Online ahead of print.ABSTRACTEpilepsy is a common pediatric neurological condition, affecting approximately 470,000 children in the USA and having a prevalence of 0.9% in the global population of approximately 2.6 billion children. Epilepsy is associated with disruptions in several areas of a child's life, including medical burden, quality of life, cognitive outcomes, and higher risk of mortality. Additionally, some pediatric patients may experience acute seizure emergencies such as seizure clusters (also called acute repetitive seizures), which are intermitten...
Source: Paediatric Drugs - October 30, 2023 Category: Pediatrics Authors: James W Wheless Barry Gidal Adrian L Rabinowicz Enrique Carrazana Source Type: research
Correction to: Viloxazine: Pediatric First Approval
Paediatr Drugs. 2023 Nov;25(6):735. doi: 10.1007/s40272-023-00599-2.NO ABSTRACTPMID:37861976 | PMC:PMC10600276 | DOI:10.1007/s40272-023-00599-2 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 20, 2023 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
